AAM
PDLI
Advisors Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-56,626
| Closed | -$136K | – | 1653 |
|
|
2018
Q1 | $136K | Sell |
56,626
-16,398
| -22% | -$39.4K | ﹤0.01% | 1286 |
|
|
2017
Q4 | $200K | Sell |
73,024
-43,940
| -38% | -$120K | ﹤0.01% | 1250 |
|
|
2017
Q3 | $397K | Sell |
116,964
-49,669
| -30% | -$169K | 0.01% | 1125 |
|
|
2017
Q2 | $412K | Sell |
166,633
-119,183
| -42% | -$295K | 0.01% | 1144 |
|
|
2017
Q1 | $649K | Sell |
285,816
-24,098
| -8% | -$54.7K | 0.01% | 1009 |
|
|
2016
Q4 | $657K | Sell |
309,914
-171,029
| -36% | -$363K | 0.01% | 1012 |
|
|
2016
Q3 | $1.61M | Sell |
480,943
-874,299
| -65% | -$2.93M | 0.03% | 696 |
|
|
2016
Q2 | $4.26M | Sell |
1,355,242
-1,006,812
| -43% | -$3.16M | 0.07% | 406 |
|
|
2016
Q1 | $7.87M | Sell |
2,362,054
-1,044,916
| -31% | -$3.48M | 0.13% | 230 |
|
|
2015
Q4 | $12.1M | Sell |
3,406,970
-1,169,198
| -26% | -$4.14M | 0.19% | 134 |
|
|
2015
Q3 | $23M | Sell |
4,576,168
-796,945
| -15% | -$4.01M | 0.37% | 45 |
|
|
2015
Q2 | $34.5M | Buy |
5,373,113
+76,665
| +1% | +$493K | 0.47% | 28 |
|
|
2015
Q1 | $37.3M | Buy |
5,296,448
+296,719
| +6% | +$2.09M | 0.5% | 30 |
|
|
2014
Q4 | $38.5M | Buy |
4,999,729
+153,944
| +3% | +$1.19M | 0.52% | 27 |
|
|
2014
Q3 | $36.2M | Buy |
4,845,785
+118,420
| +3% | +$885K | 0.5% | 35 |
|
|
2014
Q2 | $45.8M | Buy |
4,727,365
+1,051,880
| +29% | +$10.2M | 0.63% | 20 |
|
|
2014
Q1 | $30.5M | Buy |
3,675,485
+332,847
| +10% | +$2.77M | 0.46% | 42 |
|
|
2013
Q4 | $28.2M | Buy |
3,342,638
+280,399
| +9% | +$2.37M | 0.45% | 50 |
|
|
2013
Q3 | $24.4M | Buy |
3,062,239
+815,353
| +36% | +$6.5M | 0.43% | 52 |
|
|
2013
Q2 | $17.3M | Buy |
+2,246,886
| New | +$17.3M | 0.33% | 80 |
|